Nippon Soda and Syngenta enter into global licensing agreement for novel seed treatment technology
- A new active ingredient that brings innovation for control of Pythium diseases and adds a novel mode of action to leading Syngenta Seedcare portfolio
- It ensures one seed turns into one plant thus maximizing the genetic potential
- It is supported by best-in-industry expertise and the Global Seedcare Institute Network
- First commercial launch is expected in the United States and Canada in 2019
Nippon Soda and Syngenta announced today a global seed treatment licensing agreement for PICARBUTRAZOX, a new active ingredient from a novel chemical class discovered by Nippon Soda. It shows robust and reliable performance for the control of Pythium damping off and seedling blight diseases under many different cropping systems.
Tackling Pythium allows farmers to adopt reduced or no-tillage cropping systems protecting the soil, avoid the costs of having to replant and get benefits from better germination, strong stand establishment and higher yields.
Ioana Tudor, Global Head of Syngenta Seedcare, said “We are proud that Nippon Soda has partnered with Syngenta Seedcare to bring this exciting technology to the seed industry and farmers globally. PICARBUTRAZOX, with its novel mode of action will strengthen Syngenta’s leading Pythium control portfolio Mefenoxam and Azoxystrobin Technology in corn, soybeans, canola, oilseed rape, cereals and other crops”.
Chinami Yokota, Nippon Soda Director of Development Department, said “Nippon Soda has strong research capabilities and it was an excellent decision to choose Syngenta Seedcare as a leader in the seed treatment market to broaden the use of PICARBUTRAZOX beyond foliar application”.
First registrations of PICARBUTRAZOX on seed treatment are expected in the United States and Canada in 2019.
Ioana Tudor, Global Head of Syngenta Seedcare, explains the benefits of the licensing agreement to Syngenta: